Atlas Trials

Clinical Outcome and Cost-effectiveness of Reduced Noradrenaline by Using a Lower Blood Pressure Target in Patients With Cardiogenic Shock From Acute Myocardial Infarction

Clinical trial NCT05168462 · RECRUITING

Trial details

NCT number
NCT05168462
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Status
RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Cardiogenic ShockMyocardial Infarction
Start date
2022-10-01
Primary completion
2027-04-01
Enrollment
776

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.